NCT07887334Completed
Hypoglycemia Risk Assessment in Elderly and Senile Female Patients With Type 2 Diabetes Mellitus
Hypoglycemia Risk Assessment in Elderly and Senile Female Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
Hypoglycemia poses a particular danger for elderly patients with type 2 diabetes mellitus (T2DM). According to data, more than 30% of patients aged 60-69 years experience hypoglycemic episodes, and among persons over 85 years this figure exceeds 50%. The high risk is due to age-related changes: slowing of drug metabolism, decreased renal and hepatic function, weakening of counter-regulatory hormonal reactions, and impaired recognition of warning symptoms of severe hypoglycemia. The consequences of hypoglycemia in old age are especially severe, including increased risk of cardiovascular catastrophes, falls and fractures, and cognitive decline. This study aimed to identify predictors of hypoglycemia and assess its probability in elderly and senile women with T2DM for prevention in clinical practice.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 30 Jul 2026
- Start date
- Jan 2020
- Primary completion date
- Dec 2025
- Lead sponsor
- Samara State Medical University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07887334
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From Jan 2020 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Acute infectious diseases and exacerbation of concomitant chronic pathologies
- Glucocorticoid intake at the time of the study and within 1 month prior
Other illness
- Type 1 diabetes mellitus
- Oncological diseases at the time of the study
- Systemic joint and connective tissue diseases
Lab values
- Terminal stage of chronic kidney disease (eGFR less than 15 ml/min/1.73m² by CKD-EPI)
- Impaired liver function (transaminase activity exceeding 5 times the upper limit of normal)
Other
- Acute decompensation of carbohydrate metabolism at the time of the study
- Osteoarthritis of large joints with impaired joint function II-IV degree
- Severe cognitive impairments preventing survey and examination
- Presence of a pacemaker
- Bilateral endoprosthetics of large joints or metal structures in the spine
Who the study is looking for
- Female sex
- Presence of type 2 diabetes mellitus
- Signed informed consent
Age in the registry: 60 years to 86 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samara City Hospital No. 6, Endocrinology Department Coordinator of this site? Confirm its status | Samara | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.